Advertisement
Review Article| Volume 50, ISSUE 2, P217-225, May 2023

The Changing Role of Renal Mass Biopsy

Published:February 20, 2023DOI:https://doi.org/10.1016/j.ucl.2023.01.002

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Urologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Capitanio U.
        • Montorsi F.
        Renal cancer.
        Lancet. 2016; 387: 894-906
        • Turner 2nd, R.M.
        • Morgan T.M.
        • Jacobs B.L.
        Epidemiology of the small renal mass and the treatment disconnect phenomenon.
        Urol Clin North Am. 2017; 44: 147-154
        • Yang G.
        • Villalta J.D.
        • Meng M.V.
        • et al.
        Evolving practice patterns for the management of small renal masses in the USA.
        BJU Int. 2012; 110: 1156-1161
        • Patel A.K.
        • Lane B.R.
        • Chintalapati P.
        • et al.
        Utilization of renal mass biopsy for T1 renal lesions across Michigan: results from MUSIC-KIDNEY, a statewide quality improvement collaborative.
        Eur Urol Open Sci. 2021; 30: 37-43
        • Johnson D.C.
        • Vukina J.
        • Smith A.B.
        • et al.
        Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate.
        J Urol. 2015; 193: 30-35
        • Kutikov A.
        • Fossett L.K.
        • Ramchandani P.
        • et al.
        Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging.
        Urology. 2006; 68: 737-740
        • Lee S.H.
        • Park S.U.
        • Rha K.H.
        • et al.
        Trends in the incidence of benign pathological lesions at partial nephrectomy for presumed renal cell carcinoma in renal masses on preoperative computed tomography imaging: a single institute experience with 290 consecutive patients.
        Int J Urol. 2010; 17: 512-516
        • Duchene D.A.
        • Lotan Y.
        • Cadeddu J.A.
        • et al.
        Histopathology of surgically managed renal tumors: analysis of a contemporary series.
        Urology. 2003; 62: 827-830
        • Frank I.
        • Blute M.L.
        • Cheville J.C.
        • et al.
        Solid renal tumors: an analysis of pathological features related to tumor size.
        J Urol. 2003; 170: 2217-2220
        • Bhindi B.
        • Thompson R.H.
        • Lohse C.M.
        • et al.
        The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
        Eur Urol. 2018; 74: 489-497
        • Rothman J.
        • Egleston B.
        • Wong Y.N.
        • et al.
        Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis.
        J Urol. 2009; 181: 29-33
        • Palumbo C.
        • Pecoraro A.
        • Knipper S.
        • et al.
        Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology.
        Eur Urol Focus. 2021; 7: 644-652
        • Campbell S.C.
        • Clark P.E.
        • Chang S.S.
        • et al.
        Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I.
        J Urol. 2021; 206: 199-208
        • Nguyen M.M.
        • Gill I.S.
        • Ellison L.M.
        The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program.
        J Urol. 2006; 176 ([discussion: 2400]): 2397-2400
        • Ljungberg B.
        • Albiges L.
        • Abu-Ghanem Y.
        • et al.
        European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.
        Eur Urol. 2022; 82: 399-410
        • Richard P.O.
        • Violette P.D.
        • Bhindi B.
        • et al.
        Canadian Urological Association guideline: Management of small renal masses -.
        Full-text. Can Urol Assoc J. 2022; 16: E61-E75
        • Kunkle D.A.
        • Egleston B.L.
        • Uzzo R.G.
        Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.
        J Urol. 2008; 179 ([discussion: 1233-4]): 1227-1233
        • Volpe A.
        • Cadeddu J.A.
        • Cestari A.
        • et al.
        Contemporary management of small renal masses.
        Eur Urol. 2011; 60: 501-515
        • Iversen P.
        • Brun C.
        Aspiration biopsy of the kidney.
        Am J Med. 1951; 11: 324-330
        • Dechet C.B.
        • Zincke H.
        • Sebo T.J.
        • et al.
        Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults.
        J Urol. 2003; 169: 71-74
        • Herts B.R.
        • Baker M.E.
        The current role of percutaneous biopsy in the evaluation of renal masses.
        Semin Urol Oncol. 1995; 13: 254-261
        • Silverman S.G.
        • Gan Y.U.
        • Mortele K.J.
        • et al.
        Renal masses in the adult patient: the role of percutaneous biopsy.
        Radiology. 2006; 240: 6-22
        • Mickisch G.
        • Carballido J.
        • Hellsten S.
        • et al.
        Guidelines on renal cell cancer.
        Eur Urol. 2001; 40: 252-255
        • Khan A.A.
        • Shergill I.S.
        • Quereshi S.
        • et al.
        Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists.
        BMC Urol. 2007; 7
        • Barwari K.
        • de la Rosette J.J.
        • Laguna M.P.
        The penetration of renal mass biopsy in daily practice: a survey among urologists.
        J Endourol. 2012; 26: 737-747
        • Patel R.M.
        • Safiullah S.
        • Okhunov Z.
        • et al.
        Pretreatment Diagnosis of the Small Renal Mass: Status of Renal Biopsy in the United States of America.
        J Endourol. 2018; 32: 884-890
        • Mensel B.
        • Kühn J.P.
        • Kracht F.
        • et al.
        Prevalence of renal cysts and association with risk factors in a general population: an MRI-based study.
        Abdom Radiol (NY). 2018; 43: 3068-3074
        • Bosniak M.A.
        The current radiological approach to renal cysts.
        Radiology. 1986; 158: 1-10
        • O’Malley R.L.
        • Godoy G.
        • Hecht E.M.
        • et al.
        Bosniak Category IIF Designation and Surgery for Complex Renal Cysts.
        Journal of Urology. 2009; 182: 1091-1095
        • Gabr A.H.
        • Gdor Y.
        • Roberts W.W.
        • et al.
        Radiographic surveillance of minimally and moderately complex renal cysts.
        BJU International. 2009; 103: 1116-1119
        • Silverman S.G.
        • Pedrosa I.
        • Ellis J.H.
        • et al.
        Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment.
        Radiology. 2019; 292: 475-488
        • Moch H.
        • Cubilla A.L.
        • Humphrey P.A.
        • et al.
        The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours.
        European Urology. 2016; 70: 93-105
        • Lee-Felker S.A.
        • Felker E.R.
        • Tan N.
        • et al.
        Qualitative and Quantitative MDCT Features for Differentiating Clear Cell Renal Cell Carcinoma From Other Solid Renal Cortical Masses.
        American Journal of Roentgenology. 2014; 203: W516-W524
        • Young J.R.
        • Coy H.
        • Kim H.J.
        • et al.
        Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
        AJR Am J Roentgenol. 2017; 208: 812-819
        • Hindman N.
        • Ngo L.
        • Genega E.M.
        • et al.
        Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?.
        Radiology. 2012; 265: 468-477
        • Oliva M.R.
        • Glickman J.N.
        • Zou K.H.
        • et al.
        Renal Cell Carcinoma: T1 and T2 Signal Intensity Characteristics of Papillary and Clear Cell Types Correlated with Pathology.
        American Journal of Roentgenology. 2009; 192: 1524-1530
        • King K.G.
        • Gulati M.
        • Malhi H.
        • et al.
        Quantitative assessment of solid renal masses by contrast-enhanced ultrasound with time-intensity curves: how we do it.
        Abdom Imaging. 2015; 40: 2461-2471
        • Pierorazio P.M.
        • Johnson M.H.
        • Ball M.W.
        • et al.
        Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.
        Eur Urol. 2015; 68: 408-415
        • Pierorazio P.M.
        • Johnson M.H.
        • Patel H.D.
        • et al.
        Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis.
        J Urol. 2016; 196: 989-999
      1. National Comprehensive Cancer Network. Kidney Cancer (Version 1.2021). https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf. Accessed July 01, 2021.

        • Finelli A.
        • Ismaila N.
        • Bro B.
        • et al.
        Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline.
        J Clin Oncol. 2017; 35: 668-680
        • Motzer R.J.
        • Tannir N.M.
        • McDermott D.F.
        • et al.
        Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
        N Engl J Med. 2018; 378: 1277-1290
        • Rini B.I.
        • Plimack E.R.
        • Stus V.
        • et al.
        Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
        N Engl J Med. 2019; 380: 1116-1127
        • Campbell S.C.
        • Novick A.C.
        • Herts B.
        • et al.
        Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity.
        Urology. 1997; 50: 25-29
        • Patel H.D.
        • Johnson M.H.
        • Pierorazio P.M.
        • et al.
        Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma.
        Systematic Review of the Literature. J Urol. 2016; 195: 1340-1347
        • Leveridge M.J.
        • Finelli A.
        • Kachura J.R.
        • et al.
        Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy.
        Eur Urol. 2011; 60: 578-854
        • Okhunov Z.
        • Gorin M.A.
        • Jefferson F.A.
        • et al.
        Can preoperative renal mass biopsy change clinical practice and reduce surgical intervention for small renal masses?.
        Urol Oncol. 2021; 39: 735
        • Marconi L.
        • Dabestani S.
        • Lam T.B.
        • et al.
        Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy.
        Eur Urol. 2016; 69: 660-673
        • Schmidbauer J.
        • Remzi M.
        • Memarsadeghi M.
        • et al.
        Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses.
        Eur Urol. 2008; 53: 1003-1011
        • Kapur P.
        • Setoodeh S.
        • Araj E.
        • et al.
        Improving Renal Tumor Biopsy Prognostication With BAP1 Analyses.
        Arch Pathol Lab Med. 2022; 146: 154-165
        • Aminsharifi A.
        • Polascik T.J.
        Renal mass biopsy: future trends and developments.
        in: Leveillee R.J. Jorda M. Renal mass biopsy: indications, risks, technical aspects and future trends. Springer International Publishing, Cham2020: 195-207
        • Jiang P.
        • Arada R.B.
        • Okhunov Z.
        • et al.
        Multidisciplinary Approach and Outcomes of Pretreatment Small (cT1a) Renal Mass Biopsy: Single-Center Experience.
        J Endourol. 2022; 36: 703-711
        • Dutta R.
        • Okhunov Z.
        • Vernez S.L.
        • et al.
        Cost Comparisons Between Different Techniques of Percutaneous Renal Biopsy for Small Renal Masses.
        J Endourol. 2016; 30: S28-S33
        • Menhadji A.D.
        • Nguyen V.
        • Okhunov Z.
        • et al.
        Technique for office-based, ultrasonography-guided percutaneous biopsy of renal cortical neoplasms using a novel transducer for facilitated ultrasound targeting.
        BJU Int. 2016; 117: 948-953
        • Patel H.D.
        • Druskin S.C.
        • Rowe S.P.
        • et al.
        Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis.
        BJU Int. 2017; 119: 661-666
        • Volpe A.
        • Mattar K.
        • Finelli A.
        • et al.
        Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience.
        J Urol. 2008; 180: 2333-2337
        • Brachemi S.
        • Bollee G.
        Renal biopsy practice: what is the gold standard?.
        World J Nephrol. 2014; 3: 287-294
        • Sainani N.I.
        • Tatli S.
        • Anthony S.G.
        • et al.
        Successful percutaneous radiologic management of renal cell carcinoma tumor seeding caused by percutaneous biopsy performed before ablation.
        J Vasc Interv Radiol. 2013; 24: 1404-1408
        • Andersen M.F.
        • Norus T.P.
        Tumor Seeding With Renal Cell Carcinoma After Renal Biopsy.
        Urol Case Rep. 2016; 9
        • Breau R.H.
        • Crispen P.L.
        • Jenkins S.M.
        • et al.
        Treatment of patients with small renal masses: a survey of the American Urological Association.
        J Urol. 2011; 185: 407-413
        • Kutikov A.
        • Egleston B.L.
        • Canter D.
        • et al.
        Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model.
        J Urol. 2012; 188: 2077-2083
        • Patel H.D.
        • Pierorazio P.M.
        • Johnson M.H.
        • et al.
        Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.
        Clin J Am Soc Nephrol. 2017; 12: 1057-1069
        • Lane B.R.
        • Abouassaly R.
        • Gao T.
        • et al.
        Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older.
        Cancer. 2010; 116: 3119-3126
        • Danzig M.R.
        • Ghandour R.A.
        • Chang P.
        • et al.
        Active Surveillance is Superior to Radical Nephrectomy and Equivalent to Partial Nephrectomy for Preserving Renal Function in Patients with Small Renal Masses: Results from the DISSRM Registry.
        J Urol. 2015; 194: 903-909
        • Dave C.N.
        • Seifman B.
        • Chennamsetty A.
        • et al.
        Office-based Ultrasound-guided Renal Core Biopsy Is Safe and Efficacious in the Management of Small Renal Masses.
        Urology. 2017; 102: 26-30
      2. Pierorazio PM, Johnson MH, Patel HD, et al. Management of Renal Masses and Localized Renal Cancer, 2016, Rockville (MD):Agency for Healthcare Research and Quality (US); 2016 Feb. Report No.: 16-EHC001-EF.

        • Lay A.H.
        • Faddegon S.
        • Olweny E.O.
        • et al.
        Oncologic Efficacy of Radio Frequency Ablation for Small Renal Masses: Clear Cell vs Papillary Subtype.
        J Urol. 2015; 194: 653-657
        • Liu Y.
        • Du Z.
        • Zhang J.
        • et al.
        Renal mass biopsy using Raman spectroscopy identifies malignant and benign renal tumors: potential for pre-operative diagnosis.
        Oncotarget. 2017; 8: 36012-36019
        • Wagstaff P.G.K.
        • Ingels A.
        • de Bruin D.M.
        • et al.
        Percutaneous Needle Based Optical Coherence Tomography for the Differentiation of Renal Masses: a Pilot Cohort.
        J Urol. 2016; 195: 1578-1585
        • Su L.M.
        • Kuo J.
        • Allan R.W.
        • et al.
        Fiber-Optic Confocal Laser Endomicroscopy of Small Renal Masses: Toward Real-Time Optical Diagnostic Biopsy.
        J Urol. 2016; 195: 486-492
        • Bruyere F.
        • Ayoub J.
        • Arbeille P.
        Use of a telerobotic arm to perform ultrasound guidance during renal biopsy in transplant recipients: a preliminary study.
        J Endourol. 2011; 25: 231-234
        • Farber N.J.
        • Kim C.J.
        • Modi P.K.
        • et al.
        Renal cell carcinoma: the search for a reliable biomarker.
        Transl Cancer Res. 2017; 6: 620-632
        • Lakshminarayanan H.
        • Rutishauser D.
        • Schraml P.
        • et al.
        Liquid Biopsies in Renal Cell Carcinoma-Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease.
        Front Oncol. 2020; 10
        • Papworth K.
        • Sandlund J.
        • Grankvist K.
        • et al.
        Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma.
        Anticancer Res. 2010; 30: 2953-2957
        • Chopra S.
        • Liu J.
        • Alemozaffar M.
        • et al.
        Improving needle biopsy accuracy in small renal mass using tumor-specific DNA methylation markers.
        Oncotarget. 2017; 8: 5439-5448